AzTrials
AzTrials

Hearing LossNCT07156825

Adaptation of Pediatric Speech Audiometry Tests Into Other Languages

An observational study of Hearing Loss and Screening, run by Semmelweis University at 1 site in Hungary.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The objective of this study was to offer a comprehensive framework for the adaptation of speech audiometric tests into other languages. To date, this is the first universal protocol of its kind that systematically considers linguistic, phonological, and audiological aspects. Read more about this study

Who is it for?
Ages 2 to 7 yearsHealthy volunteers can take part
Conditions the study is for
Hearing Loss, Screening
How many people
120 participants
Where
1 siteHungary
Study dates
5 Aug 2024to Jul 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 to 7 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: Children aged 2-7, with normal hearing in case of control groups and with stable sensorineural hearing loss in case of hearing-impairment groups.

Who may be able to join

  • Age: limits for age groups: 2-4,5; 4,5-5,5; 5,5-7, respectively.
  • For control goups: normal hearing verified by pure tone audiometry and tympanometry
  • For hearing-impairment groups: stable sensorineural hearing loss confirmed by audiological diagnostics

Who cannot join

  • Children presenting with symptoms of upper respiratory tract infections
  • Known speech-language developmental disorders
  • Cognitive disorders

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Gergely P. Vasvari, M.D. contact

+3614864981

vasvari.gergely.pal@semmelweis.hu

Hungary1 site, 1 recruiting
  • Semmelweis University

    Budapest

    Recruiting

Other trials in Hungary

About this study

Official title: Methodological Guide for the Adaptation of Pediatric Speech Audiometry Tests Into Other Languages

The objective of this study was to offer a comprehensive framework for the adaptation of speech audiometric tests into other languages. To date, this is the first universal protocol of its kind that systematically considers linguistic, phonological, and audiological aspects.

The present paper provides a protocol and an example for adaptation and standardization of the Mainzer Audiometric Test for Children (MATCH) to another language.

Read the detailed description

To evaluate auditory function in children, speech audiometry is widely used in routine clinical settings across many countries. However, appropriate test materials are not available in several languages to date. Adapting a speech audiometry test to another language poses a significant challenge. The objective of this study was to offer a comprehensive framework for the adaptation of speech audiometric tests into other languages. To date, this is the first universal protocol of its kind that systematically considers linguistic, phonological, and audiological aspects.

The present paper is a methodological study for instrument translation; it provides a protocol and example for adaptation and standardization of the Mainzer Audiometric Test for Children (MATCH) to another language. The prospective adaptation process is divided into six phases: identifying test items and validating picture recognizability among children; ensuring linguistic conformity by comparing the phoneme distribution of the test vocabulary to spontaneous speech reference data; recording the speech material in a sound-treated environment following International Organization for Standardization (ISO) standards; equalizing the intelligibility of the recorded items through speech recognition testing in adults; standardizing the test on a cohort of normal-hearing children aged 3-6 years, stratified by age; finally, the diagnostic validity of the adapted test is evaluated by comparing speech recognition thresholds to pure-tone audiometry results in a clinical sample. Additionally, to determine sensitivity, specificity, and optimal cutoff points for detecting hearing loss, ROC analysis is used.

Keywords
Audiometry, Speech, Speech Perception, Speech Reception Threshold Test, Speech Intelligibility, Speech, Auditory Threshold, Child, Preschool
Medical subject headings
Hearing Loss, Speech, Speech Intelligibility

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07156825
Study groupRoleWhat they receive
Group 1 NChildren 2 - 4,5 years of age; with normal hearing
Group 2 NChildren 4,5 - 5,5 years of age; with normal hearing
Group 3 NChildren 5,5 - 7 years of age; with normal hearing
Group 1 PChildren 2 - 4,5 years of age; with impaired hearing
Group 2 PChildren 4,5 - 5,5 years of age; with impaired hearing
Group 3 PChildren 5,5 - 7 years of age; with impaired hearing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Correlation between SRTs obtained with the adapted MATCH and the PTA thresholds (500 Hz, 1, 2, and 4 kHz)

    The primary outcome measure is the correlation between Speech Recognition thresholds obtained with the adapted MATCH and the Pure Tone Audiometry thresholds (500 Hz, 1, 2, and 4 kHz).

    Measured: Through study completion, an average of 1 year.

Secondary outcomes (2)
  1. Test-retest reliability (intraclass correlation coefficients, ICC)

    Secondary outcome measures include test-retest reliability (intraclass correlation coefficients, ICC), to verify the reproducibility of the measurements.

    Measured: Through study completion, an average of 1 year.

  2. Diagnostic performance

    ROC analysis will be used to establish optimal cut-off points for clinical decision-making and to quantify the diagnostic performance of the test.

    Measured: Through study completion, an average of 1 year.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Sep 2025
  2. Study start5 Aug 2024
  3. Primary completionMay 2026 (estimated)
  4. Study completionJul 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07156825
Sponsor's protocol ID
SE 312/2021
Status last verified
Jan 2026
First submitted
6 Aug 2025
Last updated
26 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: It can be given out only in case of special request, with the permission of the study participants or their legal representatives.

Publications

  • Schirkonyer V, Keilmann A, Harmuth C, Wachtlin B, Rader T, Bohnert A. The new Mainz speech test for children 3-7 years old (MATCH) : Design, standardization, and validation. HNO. 2020 Jan;68(Suppl 1):43-49. doi: 10.1007/s00106-019-00793-0.

    PubMed 31915885
  • Vasvari GP, Hacki T, Vicsi K, Schirkonyer V, Tamas L, Gaborjan A. Developing the Hungarian version of the MATCH test from the original German language: an evidence-based protocol for the translation, cultural adaptation and validation of paediatric speech audiometry tests from one language into another. BMJ Open. 2026 Apr 29;16(4):e112452. doi: 10.1136/bmjopen-2025-112452.

    PubMed 42055609

Questions about this trial

What is this clinical trial studying?

An observational study of Hearing Loss and Screening, run by Semmelweis University at 1 site in Hungary.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 26 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hungary. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Gergely P. Vasvari, M.D. (+3614864981, vasvari.gergely.pal@semmelweis.hu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Correlation between SRTs obtained with the adapted MATCH and the PTA thresholds (500 Hz, 1, 2, and 4 kHz) (time frame: Through study completion, an average of 1 year.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07156825, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in